Inventor
CAMPBELL IAN BAXTER
GB11 patents
⚠️ This page may combine multiple inventors who share the name “CAMPBELL IAN BAXTER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM CORP
5 patentsUS6451794B1Sep 17, 2002
2,3-Diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2(COX-2) inhibitors
SMITHKLINE BEECHAM CORP69 citations95
US6498166B1Dec 24, 2002
Pyrazolopyridines
SMITHKLINE BEECHAM CORP56 citations93
US6831097B2Dec 14, 2004
2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
SMITHKLINE BEECHAM CORP16 citations91
US6861429B2Mar 1, 2005
2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
SMITHKLINE BEECHAM CORP14 citations90
US7223772B1May 29, 2007
Pyrazolopyridine derivatives as selective cox-2 inhibitors
SMITHKLINE BEECHAM CORP7 citations73
EUKARION INC
2 patentsGLAXOSMITHKLINE IP DEV LTD
2 patentsUS10513517B2Dec 24, 2019
Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
GLAXOSMITHKLINE IP DEV LTD11 citations82
US10144733B2Dec 4, 2018
Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
GLAXOSMITHKLINE IP DEV LTD5 citations71